Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Business
Archived
•
November 6, 2026
•
3 views
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



